FIELD: virology.
SUBSTANCE: what is described is a method for detecting recombinant forms of hepatitis C virus and hepatitis C virus drug resistance mutations to direct antiviral drugs based on a two-step polymerase chain reaction for target genes with their subsequent sequencing.
EFFECT: determination of mutations of HCV drug resistance to DAA along with possible determination of the recombinant form of the virus.
2 cl, 5 dwg, 17 tbl, 4 ex
Authors
Dates
2024-08-12—Published
2023-07-27—Filed